Medpace
3
83M
2
0.09
1
0.33
1
- Areas of investment
Summary
In 1992 was created Medpace, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Cincinnati. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Medpace, startups are often financed by Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Helix Ventures, Lilly Ventures, Daiichi Sankyo. In the next rounds fund is usually obtained by Helix Ventures, Lilly Ventures, Vivo Capital.
The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2012.
Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Coherus Biosciences. Among the most popular fund investment industries, there are Therapeutics, Biotechnology.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.09
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Manufacturing (2)
- Medical (2)
- Health Care (2)
- Therapeutics (2) Show 2 more
- Investments by region
-
- Netherlands (1)
- United States (2)
- Peak activity year
- 2021
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Coherus Biosciences | 01 Mar 2011 | Biotechnology, Health Care, Manufacturing, Medical, Therapeutics | Early Stage Venture | 1M | United States, California, Redwood City |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.